156848-83-8 | b-D-Glucopyranoside,(1R,2S,4aR,5R,8aR)-1,2,3,4,4a,5,6,8a-octahydro-5,8a-dihydroxy-1,4a-dimethyl-7-(1-methylethyl)-2-naphthalenyl | C21H36 O8 |
156848-73-6 | 11-Hexadecenoic acid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C46H78 O5 |
156848-89-4 | L-Leucinamide,N-[4-[(aminoiminomethyl)amino]-1-oxobutyl]-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-2-(2-thiazolyl)ethyl]-(9CI) | C32H49 N7 O4 S |
156848-76-9 | Octadecanoic acid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C48H84 O5 |
156848-75-8 | 11-Octadecenoic acid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C48H82 O5 |
156848-74-7 | 9,12-Octadecadienoicacid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C48H80 O5 |
156848-65-6 | Hexadecanoic acid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C46H80 O5 |
156848-72-5 | 9-Tetradecenoic acid,3-[3-hydroxy-2-(5-hydroxy-4,8,12-trimethyl-3,7,11-tridecatrienyl)-2,3-dimethyl-6-(1-methyl-2-oxoethylidene)cyclohexyl]propylester (9CI) | C44H74 O5 |
156848-68-9 | peyssonol B | C24H32 O4 |
156848-67-8 | peyssonol A | C22H29 Br O3 |